Stabel J R, Bannantine J P, Eda Shigetoshi, Robbe-Austerman S
USDA-ARS, National Animal Disease Center, 1920 Dayton Ave., Building 20, Ames, IA 50010, USA.
Clin Vaccine Immunol. 2011 Jul;18(7):1139-49. doi: 10.1128/CVI.00058-11. Epub 2011 May 4.
The objective of this study was to determine if experimental infection of neonatal calves with Mycobacterium avium subsp. paratuberculosis would invoke changes in the percentages of total B cells in the peripheral blood mononuclear cell population and of subpopulations of B cells as determined by CD5, CD25, and CD45RO markers during a 12-month period. Experimental infection groups included control (noninfected), oral (infected with M. avium subsp. paratuberculosis strain K-10), oral/DXM (pretreatment with dexamethasone before oral inoculation), i.p. (intraperitoneal inoculation), and oral/M (oral inoculation with mucosal scrapings from a cow with clinical disease) groups. Over the course of the study, the percentages of total B cells in nonstimulated and antigen-stimulated cell cultures increased for oral and i.p. group calves, with the highest percentages noted at 3 and 6 months. Oral/M group calves had increased percentages of activated B cells, as determined by CD5(dim) and CD5(bright) markers, at 9 and 12 months. Experimental infection by all methods resulted in increased expression of CD25(+) and CD45RO(+) B cells early in the study, but the most significant results were observed at 12 months for oral/DXM and oral/M group calves. Immunoblot analyses with a whole-cell sonicate of M. avium subsp. paratuberculosis demonstrated the most reactivity with sera from i.p. group calves and the least reactivity with sera from oral group calves. Further evidence of M. avium subsp. paratuberculosis-specific antibody responses in the i.p. group calves was demonstrated using the ethanol vortex enzyme-linked immunosorbent assay (EvELISA) method. In summary, an induction of B cell responses was noted after experimental infection with M. avium subsp. paratuberculosis, with differences in responses noted according to the method of experimental inoculation.
本研究的目的是确定用副结核分枝杆菌对新生犊牛进行实验性感染,是否会在12个月期间引起外周血单核细胞群体中总B细胞百分比以及由CD5、CD25和CD45RO标记物确定的B细胞亚群百分比的变化。实验感染组包括对照组(未感染)、口服组(感染副结核分枝杆菌K-10菌株)、口服/地塞米松组(口服接种前用地塞米松预处理)、腹腔注射组(腹腔接种)和口服/M组(用临床患病母牛的黏膜刮片进行口服接种)。在研究过程中,口服组和腹腔注射组犊牛的非刺激和抗原刺激细胞培养物中总B细胞百分比增加,在3个月和6个月时达到最高百分比。口服/M组犊牛在9个月和12个月时,由CD5(dim)和CD5(bright)标记物确定的活化B细胞百分比增加。所有方法的实验性感染在研究早期均导致CD25(+)和CD45RO(+)B细胞表达增加,但口服/地塞米松组和口服/M组犊牛在12个月时观察到最显著的结果。用副结核分枝杆菌全细胞超声裂解物进行的免疫印迹分析表明,与腹腔注射组犊牛的血清反应性最强,与口服组犊牛的血清反应性最弱。使用乙醇涡旋酶联免疫吸附测定(EvELISA)方法证明了腹腔注射组犊牛中存在副结核分枝杆菌特异性抗体反应的进一步证据。总之,在用副结核分枝杆菌进行实验性感染后,观察到B细胞反应的诱导,根据实验接种方法的不同,反应存在差异。